NewLake Capital Partners Reports Fourth Quarter and Full-Year 2025 Financial Results; Declared First Quarter 2026 Common Stock Dividend of $0.43 per Share (Form 8-K)

NewLake Capital Partners Reports Fourth Quarter and Full-Year 2025 Financial Results;

Declared First Quarter 2026 Common Stock Dividend of $0.43 per Share

Fourth Quarter 2025 Revenue totaled $12.3 Million

Full Year 2025 Revenue totaled $51.1 Million

Fourth Quarter 2025 Net Income Attributable to Common Stockholders totaled $6.0 Million, Funds From Operations totaled $10.0 Million, and Adjusted Funds From Operations totaled $10.6 Million

Full Year 2025 Net Income Attributable to Common Stockholders totaled $26.3 Million, Funds From Operations totaled $42.3 Million, and Adjusted Funds From Operations totaled $43.8 Million

Conference Call and Webcast Scheduled for March 6, 2026 at 11 a.m. Eastern Time

New Canaan, CT, March 5, 2026 - NewLake Capital Partners, Inc. (OCTQX: NLCP) (the "Company" or "NewLake"), a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and declared its first quarter 2026 cash dividend.

"Our fourth quarter results were in line with expectations, delivering AFFO of $0.51 per share and an AFFO payout ratio of 85%. Notably, our full-year performance exceeded 2024 levels, which is a meaningful accomplishment given the continued tenant dislocations across the industry," said Anthony Coniglio, NewLake's President and Chief Executive Officer. "As we look ahead to 2026, we are pleased to declare our first-quarter dividend of $0.43 per share. Our team remains focused on disciplined portfolio management, advancing re-tenanting initiatives, and sourcing high-quality investment opportunities to drive long-term value for our shareholders."

Fourth Quarter 2025 Financial Highlights

•Total revenue of $12.3 million.

•Net income attributable to common stockholders totaled $6.0 million, or $0.29 per share of common stock.

•Funds From Operations(1) ("FFO") totaled $10.0 million or $0.48 per share of common stock.

•Adjusted Funds From Operations(1) ("AFFO") totaled $10.6 million or $0.51 per share of common stock.

•Declared a fourth quarter dividend of $0.43 per share of common stock, equivalent to an annualized dividend of $1.72 per common share.

Full Year 2025 Financial Highlights

•Total revenue of $51.1 million.

•Net income attributable to common stockholders totaled $26.3 million or $1.28 per share of common stock.

•FFO(1) totaled $42.3 million or $2.02 per share of common stock.

•AFFO(1) totaled $43.8 million or $2.09 per share of common stock.

•For the twelve months ended December 31, 2025, the Company declared dividends of $1.72 per share of common stock.

Full Year 2025 Operational Highlights and Recent Developments

•During the year ended December 31, 2025, the Company purchased two dispensaries in Ohio for approximately $0.8 million and committed to fund approximately $1.1 million of improvements, of which the Company funded approximately $0.7 million as of December 31, 2025. The properties were leased to an existing tenant.

•During the year ended December 31, 2025, the Company completed a like-kind exchange involving the transfer of its dispensary located in Mokena, IL for a dispensary located in Brookville, PA.

•On March 4, 2026, the Company's board of directors declared a first quarter 2026 dividend of $0.43 per share of common stock.

Balance Sheet Highlights as of December 31, 2025:

•Cash and cash equivalents as of December 31, 2025 were $23.9 million, with approximately $0.4 million committed to fund improvements at an existing dispensary in Ohio.

•Total liquidity of $106.3 million, consisting of cash and cash equivalents and availability under the Company's Revolving Credit Facility.

•Gross real estate assets of $432.9 million, including one property classified as Real Estate Held for Sale.

•1.6% debt to total gross assets and a debt service coverage ratio of approximately 77.9x.

•No debt maturities until May 2027.

________________________________________________________________________________

(1) FFO and AFFO are presented on a dilutive basis.

Financial Results

The following table summarizes the Company's financial results for the three and twelve months ended December 31, 2025 (dollars in thousands, except per share amounts):

			Three Months Ended December 31,												Twelve Months Ended December 31,
			2025						2024						2025						2024
Revenue			$	12,343					12,514						$	51,071					50,131
Net Income Attributable to Common Stockholders			$	6,036					$	6,029					$	26,318					$	26,115
Net Income Attributable to Common Stockholders Per Share - Diluted			$	0.29					$	0.29					$	1.28					$	1.27
FFO Attributable to Common Stockholders - Diluted			$	10,020					$	9,922					$	42,305					$	41,278
FFO Per Share - Diluted			$	0.48					$	0.47					$	2.02					$	1.97
AFFO Attributable to Common Stockholders - Diluted			$	10,624					$	10,949					$	43,823					$	43,689
AFFO Per Share - Diluted			$	0.51					$	0.52					$	2.09					$	2.08

For the three months ended December 31, 2025, the Company generated total revenue of approximately $12.3 million, a modest decline of 1.4% compared to $12.5 million for the same period in 2024. This decrease was primarily driven by vacancies at two properties previously leased to AYR Wellness, Inc. ("AYR") and one property previously leased to Revolutionary Clinics, Inc. During the fourth quarter of 2025, the Company applied the remaining AYR security deposits of approximately $408 thousand to rent, to partially offset unpaid amounts. The impact of these vacancies, which resulted in lower rental income and additional property carrying costs, also contributed to a 3.0% decline in AFFO for the quarter compared to the same period in the prior year.

For the year ended December 31, 2025, the Company generated total revenue of approximately $51.1 million, a modest increase of 1.9% compared to $50.1 million for the same period in 2024. The increase was primarily driven by income from 2025 acquisitions, a full year of rent from properties acquired in 2024, rent generated from funded improvement allowances, annual contractual rent escalations and the timing of reimbursable revenue, partially offset by the impact of vacancies. Together, these revenue drivers, partially offset by the impact of vacancies, also contributed to a modest 0.3% increase in AFFO for the year ended December 31, 2025.

2025 Investment Activity

Acquisitions

The following table presents the Company's investment activity for the twelve months ended December 31, 2025 (dollars in thousands):

Tenant

Market

Site Type

Closing Date

Acquisition

Cresco Labs

Ohio

Dispensary

February 19, 2025

$

285

Cresco Labs

Ohio

Dispensary

April 25, 2025

500

Curaleaf

(1)

Pennsylvania

Dispensary

June 12, 2025

950

Total

$

1,735

(1) This dispensary was acquired through a like-kind exchange and was recorded at its fair value.

Real Estate Commitments

Improvement Allowances

The following table presents the funded and remaining unfunded commitments for the twelve months ended December 31, 2025 (dollars in thousands):

Tenant						Market						Site Type						Closing Date						Funded Commitments						Unfunded Commitments
Cresco Labs						Ohio						Dispensary						February 19, 2025						$	705					$	-
Cresco Labs						Ohio						Dispensary						April 25, 2025						-						375
Total																								$	705					$	375

Portfolio and Tenant Updates

Hartford, CT Cultivation Facility

In October 2025, the Company amended its lease agreements with C3 Industries ("C3"). Under the amended Hartford, CT lease, the Company agreed to pursue a sale of the Hartford, CT property, and in connection with that agreement, C3 is required to reimburse the Company for any shortfall if the sale proceeds are less than the Company's investment basis. Conversely, if sale proceeds exceed the Company's basis, a portion of the excess will be paid to C3 as reimbursement for their investment in the property. C3 will continue to pay monthly base rent through the sale date. Upon completion of the sale, a portion of the rent previously allocated to the Hartford, CT property will be reallocated to the Missouri lease, to compensate the Company for a portion of the income no longer received from the Hartford, CT property. C3 will continue to pay incremental rent under the Missouri lease until the Company invests in new properties with C3 pursuant to its right of first refusal agreement. In November 2025, the Company entered into an agreement with a broker to market the Hartford, CT property for sale.

Financing Activity

Revolving Credit Facility

As of December 31, 2025, the Company had $7.6 million in borrowings outstanding under its Revolving Credit Facility and $82.4 million in funds available to be drawn, subject to sufficient collateral in the borrowing base. The Revolving Credit Facility bears interest at a variable rate based upon the greater of (a) the Prime Rate quoted in the Wall Street Journal (Western Edition) ("Base Rate") plus an applicable margin of 1.0% or (b) 4.75%. As of December 31, 2025, the interest rate was 7.75%.

As of December 31, 2025, the Company was in compliance with the covenants under the agreement.

Dividend

On December 15, 2025, the Company's board of directors declared a fourth quarter 2025 cash dividend of $0.43 per share of common stock, equivalent to an annualized dividend of $1.72 per share of common stock. The dividend was paid on January 15, 2026 to stockholders of record at the close of business on December 31, 2025 and represents an AFFO payout ratio of 85%.

For the year ended December 31, 2025, the Company's board of directors declared an aggregate cash dividends of $1.72 per share of common stock and represents an annual AFFO payout ratio of 82%. The dividend has grown 79% since the Company's initial public offering in 2021.

On March 4, 2026, the Company's board of directors declared a first quarter 2026 cash dividend of $0.43 per share of common stock, equivalent to an annualized dividend of $1.72 per share of common stock. The dividend is payable on April 15, 2026 to stockholders of record at the close of business on March 31, 2026.

Recent Development

The Cannabist Company ("Cannabist") is currently operating under a forbearance agreement with its senior noteholders, which has been extended through March 6, 2026. As of the date of this release, the Cannabist remains in compliance with all material terms of its lease agreement with the Company. The Company continues to monitor the situation. Refer to our Form 10-K for details.

Conference Call and Webcast Details:

Management will host a conference call and webcast at 11:00 a.m. Eastern Time on March 6, 2026 to discuss its fourth quarter and full year 2025 financial results and answer questions about the Company's operational and financial highlights.

Event:			NewLake Capital Partners Inc. Fourth Quarter and Full Year 2025 Earnings Call
Date:			Friday, March 6, 2026
Time:			11:00 a.m. Eastern Time
Live Call:			1-877-407-3982 (U.S. Toll-Free) or +1-201-493-6780 (International)
Webcast:			https://ir.newlake.com/news-events/ir-calendar

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until March 20, 2026 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 13758166.

About NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects. As of December 31, 2025, NewLake owns a portfolio of 34 properties comprised of 15 cultivation facilities and 19 dispensaries that are primarily leased to single tenants on a triple-net basis. For more information, please visit www.newlake.com.